The Interaction Between Vasculogenic Mimicry and the Immune System: Mechanistic Insights and Dual Exploration in Cancer Therapy
Cell Proliferation · 2025
DOI: 10.1111/cpr.13814 ↗At a glance
Übersichtsarbeit in Cell Proliferation, 2025. Written by Shutong Liu and 14 co-authors. Institution: Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Major MEDLINE topics: Neoplasms, Neovascularization, Pathologic, Immune System. Cited 16 times so far (Crossref); 122 references. The full text is freely available (open access, CC BY 4.0). Funded by: the Major Science and Technology projects of Henan Province.
Abstract (original language)
Vasculogenic mimicry (VM) represents a novel form of angiogenesis discovered in numerous malignant tumours in recent years. Unlike traditional angiogenesis, VM facilitates tumour blood supply independently of endothelial cells by enabling tumour cells to form functional vascular networks. This phenomenon, where tumour cells replace endothelial cells to form tubular structures, plays a pivotal role in tumour growth and metastasis. Tumour progression is influenced by a variety of factors, including immune components. The immune system serves as a critical defence mechanism by identifying and eliminating abnormal entities, such as tumour cells. This inevitably reminds us of the intricate connection between the immune system and VM. Indeed, in recent years, some studies have shown that immune responses and related immune cells play different regulatory roles in the formation of VM. Therefore, this review provides a comprehensive discussion on the mechanisms underlying VM formation, its interplay with the immune system, and the potential of leveraging immunotherapy to target VM.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Medical School of Zhengzhou University, Zhengzhou, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Richard Dimbleby Department of Cancer Research, Comprehensive Cancer Centre, Kings College London, London, UK.
- The Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
ORCID profiles: Peng Luo, Quan Cheng, Xinwei Han, Zaoqu Liu
Funding
- the Major Science and Technology projects of Henan Province
Cite
APA
Liu, S., Kang, M., Ren, Y., Zhang, Y., Ba, Y., Deng, J., Luo, P., Cheng, Q., Xu, H., Weng, S., Zuo, A., Han, X., Liu, Z., Pan, T., & Gao, L. (2025). The Interaction Between Vasculogenic Mimicry and the Immune System: Mechanistic Insights and Dual Exploration in Cancer Therapy. Cell Proliferation. https://doi.org/10.1111/cpr.13814
Vancouver
Liu S, Kang M, Ren Y, Zhang Y, Ba Y, Deng J, et al. The Interaction Between Vasculogenic Mimicry and the Immune System: Mechanistic Insights and Dual Exploration in Cancer Therapy. Cell Proliferation. 2025. doi:10.1111/cpr.13814
BibTeX
@article{Liu2025,
author = {Liu, Shutong and Kang, Mei and Ren, Yuqing and Zhang, Yuyuan and Ba, Yuhao and Deng, Jinhai and Luo, Peng and Cheng, Quan and Xu, Hui and Weng, Siyuan and Zuo, Anning and Han, Xinwei and Liu, Zaoqu and Pan, Teng and Gao, Li},
title = {The Interaction Between Vasculogenic Mimicry and the Immune System: Mechanistic Insights and Dual Exploration in Cancer Therapy},
journal = {Cell Proliferation},
year = {2025},
doi = {10.1111/cpr.13814}
}
EUVIMED